Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Review Article
Author Details :
Volume : 7, Issue : 2, Year : 2021
Article Page : 270-274
https://doi.org/10.18231/j.ijceo.2021.056
Abstract
The COVID 19 pandemic has brought about a change in the lifestyle of one and all with the healthcare workers being no exception. The objective of this review is to discuss the problems faced during the COVID19 pandemic especially by the ophthalmological community owing to the close contact with the patient during examination which is inevitable. The text has been written after a thorough literature search of articles on Pubmed using relevant keywords. It discusses and brings forth the ways of ophthalmological practices to minimize the risk of exposure being followed across the world as laid down by the ophthalmological societies of various countries and regions. The importance of social distancing and the role of tele-ophthalmology which formed the cornerstone of treatment during this hour of crisis has also been discussed.
Keywords: COVID 19, Ophthalmology, Teleophthalmology.
How to cite : Sinha P, Raj A, Kumar A, Sinha U, Ophthalmological practices in COVID times. Indian J Clin Exp Ophthalmol 2021;7(2):270-274
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.